Third of psoriasis patients haven't had treatment reviewed for at least five years┬╣

Lack of regular review highlighted by survey could mean that serious comorbidities such as diabetes, heart disease, high blood pressure and cancer are missed.

Click here to view the full press release in pdf format.

1. Opinion Matters Survey, Patient with Psoriasis Receiving a Repeat Prescription, LEO Pharma, Data on File, May 2014

Cookies on this site

LEO Laboratories Limited uses cookies to give you the best experience online and to provide anonymised, aggregated site usage data. You can find out what cookies we use, what they do and how you can disable them in our Cookie Policy. By browsing our sites, you consent to the use of cookies. If you want to know more about our cookie policy and how to avoid and delete cookies click here. By continuing to browse this site, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.